News

Novartis announced that the US Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to Kymriah (tisagenlecleucel), for an investigational…
Read More...

After cities shut down and citizens were urged to stay home to slow the spread of Covid-19, scientists in major cities like Boston were suddenly far removed from their labs. At MIT,…
Read More...

Targovax ASA, a clinical stage immuno-oncology company developing oncolytic viruses and cancer vaccines to target hard-to-treat solid tumors, and Valo Therapeutics (Valo Tx) announce…
Read More...

Asklepios BioPharmaceutical, Inc. (AskBio) announced that it has acquired BrainVectis, a Paris-based gene therapy company and French National Institute for Health and Medical Research…
Read More...

Aptar and Sonmol have announced a collaboration for developing a digital therapies and services platform targeting respiratory and other diseases. This collaboration will initially…
Read More...

Mogrify Ltd (Mogrify), a UK company aiming to transform the development of cell therapies by the systematic discovery of novel cell conversions, and Sangamo Therapeutics (Sangamo), a…
Read More...

Boehringer Ingelheim announced that the European Commission has approved nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults. The…
Read More...

Nexus Pharmaceuticals announced that it has received U.S. Food and Drug Administration (FDA) approval for its patent-pending New Drug Application (NDA) Emerphed, the first and only…
Read More...

Novartis announced new Mayzent (siponimod) data in the April supplemental issue of Neurology, the medical journal of the American Academy of Neurology. The data build on existing…
Read More...

Gilead Sciences, Inc. Kite, a Gilead Company, and oNKo-innate announced the companies have entered into a three-year cancer immunotherapy research collaboration to support discovery and…
Read More...

Hope Biosciences announces FDA approval on their third clinical trial for COVID-19. This study will be conducted in collaboration with Advanced Diagnostics Healthcare (ADH) at River…
Read More...

Anixa Biosciences, Inc. announced that it has entered into a strategic collaboration with OntoChem GmbH to discover and develop anti-viral drug candidates for COVID-19. Dr. Amit…
Read More...

Amblyotech, a US-based digital therapeutics company, announced that it has completed the sale of all of its outstanding shares to Novartis pursuant to a Share Purchase Agreement entered…
Read More...

Alexion Pharmaceuticals, Inc. announced plans to initiate a global Phase 3 study to investigate ULTOMIRIS (ravulizumab-cwvz) in a subset of adults with COVID-19 – those who are…
Read More...

Wavelength Pharmaceuticals, a leading supplier of active pharmaceutical ingredients (APIs), reported that it has greatly expanded production of APIs for certain pharmaceutical products…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and the European Medicines Agency (EMA) has…
Read More...

RedHill Biopharma Ltd. announced that it has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health…
Read More...

SOM Biotech announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19. The three candidates inhibit the main protease of SARS-CoV-2 and…
Read More...

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of…
Read More...

According to the website of the U.S. Food and Drug Administration ("FDA"), Shanghai Fosun Pharmaceutical (Group) Co., Ltd  has received emergency use authorization (EUA) from FDA for…
Read More...